How to Launch a Supplement in Canada: 2026 NPN Guide

Updated LumaNutra Team12 min readregulatorycanadanpngetting-started

Launch a supplement in Canada: NPN application steps, GMP manufacturing partners, bilingual labeling, Health Canada timelines, and realistic starter budgets.

How to Launch a Supplement in Canada: 2026 NPN Guide

To legally sell a supplement or natural health product in Canada, you need a Natural Product Number (NPN) from Health Canada, manufacturing at a facility with a valid Site Licence, and a bilingual English and French label. Canada is a strong market, but the regulatory bar is higher than most US-based founders expect the first time they look at it. This guide walks through what the process actually looks like, what it costs, and where first-time founders get stuck.

Every natural health product sold in Canada (every vitamin, every probiotic, every herbal extract) needs a licence from Health Canada before it can legally touch a shelf. The eight-digit number on that licence is the NPN, and getting it is the single biggest thing that separates "I have an idea" from "I have a product for sale in Canada" (Health Canada, Natural Health Products Regulations).

How big is the Canadian natural health product market?

The Canadian natural health product category is worth more than $6 billion CAD and still growing, according to industry data tracked by the Canadian Health Food Association. Canadian consumers are well-educated and will pay for quality, but they also expect to see an NPN on the bottle. That number is issued by Health Canada after it reviews the product's safety, efficacy, and quality, and it is the trust signal Canadian retailers and shoppers key off of. A higher barrier to entry means more work up front, and more trust on the shelf once you are through it.

How does the NPN application process work?

The NPN submission is the work. Everything else flows from it.

Here is what Health Canada is checking when it reviews a product licence application:

  • Safety. Are the ingredients and doses safe for the intended consumer?
  • Efficacy. Is there enough evidence for the claims on the label?
  • Quality. Is the product being made under GMP at a facility with a valid Site Licence?

There are two main routes through the submission process:

Compendial (monograph-based) applications use ingredients and claims that are already on Health Canada's approved monograph list. These are faster because the evidence is already accepted. A simple Class I multivitamin submission against a monograph can clear in roughly 60 days if everything is in order.

Non-compendial applications are for novel ingredients, novel combinations, or claims not covered by a monograph. You submit the full evidence package: clinical studies, traditional-use references, and pharmacopoeial data. These take longer (often 6 to 12 months) and fail more often, usually because the evidence package is not thorough enough.

A few things make a submission go smoothly:

  • Lean on monographs wherever you can. Every piece of evidence you do not have to submit is a week of review time you do not have to wait through.
  • Build the product specifications and evidence package together. Missing information is the number-one cause of clarification requests and refusals.
  • Assume it takes longer than the Health Canada target timeline. Backlogs happen.
  • If you have never done this before, hire a regulatory consultant. The fee is small compared to the cost of a rejection. LumaNutra coordinates this end to end inside our NPN application service.

How do you pick a Canadian supplement manufacturer?

Health Canada requires every NHP sold in Canada to be made at a facility operating under the Natural Health Products GMP framework. That facility needs a valid Site Licence. Your manufacturer is part of your regulatory paperwork as well as your supply chain, and they need to hold up under an audit. Our Canadian manufacturing network is concentrated in two provinces, which is worth understanding before you start calling facilities.

Things worth asking before you sign anything:

  • Site Licence. Ask for the number. Verify it on Health Canada's Licensed Natural Health Products Database. Do not accept "we are working on it."
  • Format fit. Can they actually run your dosage form? Capsule facilities are not gummy facilities, and the capability list on the website is sometimes optimistic.
  • MOQs. Some facilities will not run less than 50,000 units per batch. Others will do 1,000. Find out before you get attached.
  • Testing and quality assurance. In-house labs? Third-party partners? What does their batch release look like?
  • Room to scale. Can this facility grow with you? If you hit product-market fit, the worst time to find out your manufacturer cannot keep up is when you are already sold out.

A good manufacturing partner communicates without being chased, gives realistic timelines, and flags issues early. If you are interviewing a facility and those things are not happening in the sales process, it will not improve after you sign. Most LumaNutra clients route through our private and white label manufacturing so we manage the partner network for them.

Which province should you manufacture in?

Almost all Canadian supplement manufacturing capacity sits in two provinces, and they are good at different things.

Ontario holds the largest concentration of GMP-certified supplement manufacturing facilities in the country. It covers the widest range of dosage forms: capsules, tablets, softgels, powders, gummies, stick packs, liquids, and chewables. Facilities there tend to have long NPN track records and are familiar with what Health Canada auditors expect, which matters more than founders assume on a first submission. The Toronto and Mississauga logistics corridor also makes domestic fulfillment fast, and the same facilities are used to serving US East Coast customers. If you are in Toronto, the GTA, Ottawa, Hamilton, or anywhere across Southwestern Ontario, staying in province removes a lot of shipping and coordination friction.

British Columbia is smaller but has two things Ontario does not always offer. Our BC network includes in-province R&D and formulation development, so prototyping and stability work can run through the same partners that manufacture the finished product. It also runs stick packs at low minimums, well below the 40,000-unit entry point the format usually carries. Coverage there is tablets, capsules, powders, liquids, and stick packs. Proximity to the Port of Vancouver gives BC brands the better import economics on raw materials, and the West Coast position suits brands distributing into the US Pacific states.

A few practical notes on the choice:

  • You do not have to manufacture in the province you sell in. NHP regulation in Canada is federal, so a valid NPN covers every province regardless of where the product was made.
  • Match the province to the dosage form first and to your address second. A gummy project belongs in Ontario even if you are based in Vancouver.
  • MOQs across our Canadian partners start at 2,000 units for most standard formats, which is low enough to launch a single SKU without committing to a full retail rollout.

Why you should not finalize your label before the NPN comes back

Canadian NHP labels are heavily regulated. Every label needs:

  • The NPN or DIN-HM number
  • Product name and dosage form
  • Medicinal ingredients with per-dose quantities
  • Non-medicinal ingredients in descending order of quantity
  • The approved recommended use or purpose (this is the claim)
  • Recommended dose
  • Risk information (cautions, warnings, contraindications, adverse reactions)
  • Storage conditions if applicable
  • Every element in both English and French. Bilingual labeling is a legal requirement in Canada, not a nice-to-have (Health Canada NHP labelling guidance).

The most expensive mistake we see at this stage is printing the label before the NPN is issued. Health Canada frequently modifies claim language during the review. If your label says one thing and the approved claim says another, you reprint. Lock your final label copy after the NPN comes back, not before. This is one of the common mistakes supplement brands make on launch, and it is avoidable.

What sets your launch date and your budget

Two things surprise first-time founders here, and neither is the factory.

The regulatory file is the critical path on almost every Canadian launch. A monograph-aligned Class I submission clears considerably faster than a Class II or III file built from its own evidence package, and that gap is the single largest variable in your schedule. Everything downstream waits on it.

The other surprise is where the money goes. The first production run is the largest single line item by a wide margin. Formulation consulting, the NPN submission, label design, and testing together usually come to a fraction of it, which catches out founders who assume the paperwork dominates.

What moves your number:

DriverCosts lessCosts more
Formula originA catalog formula with an existing NPNCustom development with stability work
Regulatory pathwayMonograph-aligned Class INon-compendial Class II or III
Dosage formCapsules, tablets, powdersGummies, softgels, functional beverages
Run sizeA single SKU at the minimumMulti-SKU or high volume
PackagingStock bottle and bilingual labelCustom cartons and specialty materials

Whatever the mix, hold something back for the things you cannot predict. A reformulation request from Health Canada, a raw material delay, a packaging supplier that misses a date. Something always comes up. Builds with a contingency finish on time. Builds without one stall.

What should a founder do first?

The Canadian market rewards founders who do the regulatory work up front. It punishes the ones who skip it. The good news is that once you are through the NPN process, you have something US-only competitors do not: a product that has been reviewed by a government health authority, and a label that signals it.

If you are trying to figure out whether your product concept is even viable under Health Canada's framework, the most useful thing you can do before spending money on formulation is a regulatory scoping session. A good consultant can tell you in an hour whether your claims will clear, whether your ingredients are on a monograph, and roughly what the submission pathway looks like. It is the cheapest insurance policy in the process.

That is the kind of work we do at LumaNutra every day: regulatory scoping, NPN submissions, GMP manufacturing coordination, and bilingual label design for brand founders launching into Canada. If you are stuck on any piece of it, tell us what you are working on and we will tell you honestly what we would do next.

FAQ

Do I need an NPN to sell supplements in Canada?

Yes. Every natural health product sold in Canada, from vitamins to probiotics to herbal extracts, needs a Natural Product Number (NPN) or DIN-HM issued by Health Canada before it can be legally sold. The NPN is issued after Health Canada reviews the product's safety, efficacy, and quality, and the number must appear on the bottle.

How long does it take to get an NPN from Health Canada?

Most submissions take between 60 days and 12 months. A simple Class I multivitamin filed against an approved monograph can clear in around 60 days. Non-compendial submissions that rely on novel ingredients, novel combinations, or claims outside a monograph often take 6 to 12 months. Plan for the longer end and assume backlogs.

What is the difference between a compendial and non-compendial NPN application?

A compendial application uses ingredients and claims already on Health Canada's approved monograph list, so the evidence is pre-accepted and review is faster. A non-compendial application is for novel ingredients, novel combinations, or claims that fall outside the monographs, and you submit the full evidence package yourself. Non-compendial submissions take longer and fail more often.

Do all Canadian supplement labels need to be bilingual?

Yes. Every element of an NHP label, including the medicinal ingredients, the non-medicinal ingredients, the recommended use, the dose, and the risk information, must appear in both English and French. Bilingual labeling is a legal requirement in Canada, not an optional best practice.

How much does it cost to launch a supplement in Canada?

It is quoted per project, because a handful of decisions move the number more than anything else: whether you start from a catalog formula or develop one, the regulatory pathway your claims require, the dosage form, the run size, and how custom the packaging is. The first production run is the largest single line item in almost every case. Formulation consulting, the NPN submission, label design, and testing together come to a fraction of it.

Can I use a US manufacturer for a product sold in Canada?

Only if that manufacturer holds a valid Health Canada Site Licence for the dosage form you are running. The facility forms part of your regulatory filing, so the Site Licence has to be confirmed in Health Canada's public database before you can ship product into Canada under an NPN.

Where in Canada are supplements manufactured?

Almost all Canadian capacity sits in Ontario and British Columbia. Ontario holds the largest concentration of GMP-certified facilities and the widest dosage-form coverage, including gummies and softgels. British Columbia is smaller, offers in-province R&D and formulation development, and runs stick packs at minimums well below the 40,000 units the format usually requires.

Do I have to manufacture in the same province where I sell?

No. Natural health product regulation in Canada is federal, so a valid NPN covers sales in every province no matter where the product was made. Choose the facility by dosage form and capability rather than by proximity to your own address.

What is the minimum order quantity for a supplement made in Canada?

MOQs across our Canadian partner facilities start at 2,000 units for most standard dosage forms. Specialty formats carry their own minimums. Stick packs normally start around 40,000 units industry-wide, though our British Columbia network runs them lower.


This article reflects general industry observations and is not legal or regulatory advice. Always verify Health Canada requirements (or consult qualified counsel) before launching a health product.

Stay in the loop

Get the latest insights on health product development, regulatory updates, and brand strategy delivered to your inbox.